Top compounds associated with response to TMEM164


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA GDC-0941 FIMM pan-cancer AAC 0.56 0.001
mRNA PI-103 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.16 0.002
mRNA BIBW2992 FIMM pan-cancer AAC 0.45 0.002
mRNA PD-0325901 gCSI pan-cancer AAC 0.15 0.003
mRNA AZD6244 CCLE pan-cancer AAC 0.13 0.004
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.087 0.005
Download CSV